Skip to main content
ATOSSA THERAPEUTICS, INC. logo

ATOSSA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · ATOS ISIN · US04962H5063 US Manufacturing
Filings indexed 622 across all filing types
Latest filing 2017-05-11 Regulatory Filings
Country US United States of America
Listing US ATOS

About ATOSSA THERAPEUTICS, INC.

https://atossatherapeutics.com/

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative medicines for areas of significant unmet medical need, with a primary focus on oncology. The company is dedicated to addressing the full continuum of breast cancer care. Its lead program is centered on (Z)-endoxifen, a proprietary and potent selective estrogen receptor modulator (SERM). Atossa is advancing (Z)-endoxifen through clinical development for multiple breast cancer indications, including metastatic disease, aiming to provide a therapeutic with a potentially improved efficacy and tolerability profile.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes: (1) a press release announcing first quarter 2017 financial results and company update, (2) a notice of delisting due to non-compliance with NASDAQ bid price rule, and (3) submission of matters to a vote of security holders at the 2017 Annual Meeting with detailed voting results. The document is not a full annual or quarterly report but a regulatory filing reporting multiple events including voting results and delisting notice. The presence of voting results from the Annual Meeting aligns with the category "Declaration of Voting Results & Voting Rights Announcements (DVA)". Additionally, the delisting notice is present but the main body is a current report covering multiple items. Since the document is a Form 8-K with multiple items including voting results, the best fitting category is Regulatory Filings (RNS) as a fallback for miscellaneous filings that do not fit neatly into other categories. The document is not solely a voting results declaration or delisting announcement but a combined current report. Therefore, the classification is RNS with high confidence.
2017-05-11 English
10-Q
Interim / Quarterly Report Q1 2017
2017-05-11 English
4
Director's Dealing
2017-04-18 English
DEF 14A
Proxy Solicitation & Information Statement
2017-04-13 English
8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated March 28, 2017, reporting the entry into a material definitive agreement related to a public offering of securities. It details the underwriting agreement, the types and amounts of securities offered, and the closing of the offering. The document includes exhibits such as the underwriting agreement and form of warrant. This type of filing is an update on capital raising activities and financing arrangements, which fits the category of Capital/Financing Update (CAP). The document is not a full financial report, earnings release, or management discussion, but a regulatory filing specifically about financing activity.
2017-04-04 English
424B3
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus filed pursuant to Rule 424(b)(3) under the Securities Act, describing an offering of Class A and Class B units consisting of common stock, preferred stock, and warrants. It includes detailed information about the securities offered, underwriting, risk factors, use of proceeds, and company business overview. This type of document is a registration prospectus related to capital raising activities, not a financial report, earnings release, or management discussion. It is not an announcement of a report but the actual offering document. Therefore, it fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2017-03-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.